<DOC>
	<DOCNO>NCT00242281</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy APC 111 MP Tablet , 775 mg tablet , give orally ( PO ) daily ( QD ) 10 day compare Penicillin VK , 250 mg PO four time daily ( QID ) 10 day term bacteriological outcome Test-of-Cure ( TOC ) Visit ( Day 14-18 ) eligible Per-Protocol bacteriological ( PPb ) population .</brief_summary>
	<brief_title>APC-111 MP Tablet Once Day vs.Penicillin VK Four Times Day Both 10 Days Patients With Strep Throat</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Tonsillitis</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Penicillin V</mesh_term>
	<criteria>Informed consent/assent Age 12 old A clinical diagnosis acute tonsillitis and/or pharyngitis define clinical sign symptom compatible tonsillitis and/or pharyngitis , include sore throat pharyngeal erythema least one following : Odynophagia Tonsillar pharyngeal exudate Tender cervical lymph node Fever history fever treat antipyretic Chills Uvular edema Elevated white blood cell count Red tongue prominent papillae A positive rapid screen test S. pyogenes Subject appropriate candidate oral antibiotic therapy swallow study dosage form Females must nonlactating : At risk pregnancy one follow reason : postmenopausal least one year , hysterectomy , tubal ligation , abstinent sexual activity could result pregnancy , OR If childbearing potential sexually active , patient must negative baseline urine pregnancy test utilize acceptable contraceptive throughout study . If child bear potential currently sexually active , patient must negative baseline urine pregnancy test must agree remain abstinent duration study . If decide become sexually active period study , must agree use acceptable contraception . Are able comply requirement protocol Chronic recurrent odynophagia enlarge tonsil obscure etiology More one episode acute tonsillitis and/or pharyngitis 6 month prior baseline visit Pharyngitis know suspect due pathogen resistant βlactam antimicrobial Subjects known carrier S. pyogenes Previous allergy , serious adverse reaction , intolerance penicillin member βlactam class antimicrobial , include cephalosporin Any serious illness concomitant condition Investigator judge would preclude study evaluation make unlikely course study therapy followup could complete . This would also include : Any rapidly progressive underlie disease shorten life expectancy The inability swallow study dosage form Unable understand requirement study Neutropenia ( &lt; 1000 PMNs/mm3 ) immunocompromised state . Concurrent condition upper/lower respiratory tract infection Concurrent symptom viral etiology include : conjunctivitis , coryza , cough diffuse adenopathy rash suggestive mononucleosis rash arthropathy suggestive scarlet fever Seizure disorder , lower seizure threshold , psychiatric condition require use major tranquilizer Pregnancy nurse Expectation additional effective systemic antibacterial would require condition duration study Current drug alcohol abuse Receipt experimental drug medical device within previous 30 day Previous treatment protocol The need hospitalization I.V . antimicrobial therapy Previous systemic antimicrobial therapy within 30 day The presence clinically significant hematologic condition History cardiovascular disease , renal disease , neurological disease secondary previous infection S. pyogenes previous rheumatic fever Probenecid treatment systemic steroid 7 day prior baseline visit throughout duration study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>Sore Throat</keyword>
	<keyword>Pharyngitis</keyword>
	<keyword>Tonsillitis</keyword>
</DOC>